Pfizer, Inc. (PFE) financial statements (2022 and earlier)

Company profile

Business Address 235 E 42ND ST
NEW YORK, NY 10017
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments31,06912,2219,83018,83319,99217,85023,290
Cash and cash equivalents1,9441,7841,3051,1391,3422,5953,641
Short-term investments29,12510,4378,52517,69418,65015,25519,649
Receivables11,4797,9308,7248,0258,2218,2258,176
Inventory, net of allowances, customer advances and progress billings9,0598,0468,2837,5087,5786,7837,513
Inventory9,0598,0468,2837,5087,5786,7837,513
Disposal group, including discontinued operation 167219,72512801 
Other current assets3,8203,4382,6002,4612,2892,2492,163
Other undisclosed current assets4,2663,2653,3453,3743,0493,0412,662
Total current assets:59,69335,06732,80349,92641,14138,94943,804
Noncurrent Assets
Inventory, Noncurrent 890714618683683594
Operating lease, right-of-use asset 1,3931,313
Property, plant and equipment14,88213,90013,96713,38513,86513,31813,766
Long-term investments and receivables 20,2623,0142,7677,0157,11615,999
Long-term investments 20,2623,0142,7677,0157,11615,999
Intangible assets, net (including goodwill)74,35478,04894,02388,622104,693107,09788,598
Goodwill49,20849,57758,65353,41155,95254,44948,242
Intangible assets, net (excluding goodwill)25,14628,47135,37035,21148,74152,64840,356
Other noncurrent assets7,6794,5694,4502,7993,2273,3233,499
Other undisclosed noncurrent assets24,86810017,2051,3051,1731,1291,200
Total noncurrent assets:121,783119,162134,686109,496130,656132,666123,656
TOTAL ASSETS:181,476154,229167,489159,422171,797171,615167,460
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,42510,57810,02410,3839,3589,4048,249
Accounts payable5,5784,3094,2204,6744,6564,5363,620
Employee-related liabilities3,3323,0582,7202,3972,1962,4872,359
Taxes payable1,2661,0499801,265477437418
Interest and dividends payable2,2492,1622,1042,0472,0291,9441,852
Deferred revenue3,067  
Debt2,2412,70316,1958,8319,95310,68810,160
Other liabilities24,93912,64011,08310,75311,11511,02310,990
Other undisclosed current liabilities(1)(1)21,8911  
Total current liabilities:42,67125,92037,30431,85830,42731,11529,399
Noncurrent Liabilities
Long-term debt and lease obligation36,19537,13335,95532,90933,53831,39828,818
Long-term debt, excluding current maturities36,19537,13335,95532,90933,53831,39828,818
Liabilities, other than long-term debt25,14727,70330,78327,19732,27649,26244,245
Deferred tax liabilities, net  30,75326,877
Deferred income tax liabilities3494,0635,578
Liability for uncertainty in income taxes11,33111,56012,12614,73718,6974,0003,992
Liability, pension and other postretirement and postemployment benefits3,7245,4116,7626,6107,4308,1728,119
Other liabilities9,7436,6696,3175,8506,1496,3375,257
Other undisclosed noncurrent liabilities   3,7003,90011
Total noncurrent liabilities:61,34264,83666,73863,80669,71480,66173,064
Total liabilities:104,01390,756104,04295,664100,141111,776102,463
Stockholders' equity
Stockholders' equity attributable to parent, including:77,20163,23863,14363,40771,30859,54464,720
Preferred stock  1719212426
Common stock473470468467464461459
Treasury stock, value(111,361)(110,988)(110,801)(101,610)(89,425)(84,364)(79,252)
Additional paid in capital90,59188,67487,42886,25384,27882,68581,016
Accumulated other comprehensive loss(5,897)(11,688)(11,640)(11,275)(9,321)(11,036)(9,522)
Retained earnings103,39496,77097,67089,55485,29171,77471,993
Other undisclosed stockholders' equity attributable to parent1 1(1)   
Stockholders' equity attributable to noncontrolling interest262235303351348296278
Other undisclosed stockholders' equity(1) 1    
Total stockholders' equity:77,46263,47363,44763,75871,65659,84064,998
Other undisclosed liabilities and equity1    (1)(1)
TOTAL LIABILITIES AND EQUITY:181,476154,229167,489159,422171,797171,615167,460

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues81,28841,90851,75053,64752,54652,82448,851
Revenue, net52,54652,82448,851
Cost of revenue
(Cost of Goods and Services Sold)
(30,821)(8,692)(10,219)(11,248)(11,240)(12,329)(9,648)
Gross profit:50,46733,21641,53142,39941,30640,49539,203
Operating expenses(27,314)(21,610)(23,684)(23,503)(22,924)(24,306)(27,329)
Operating income:23,15311,60617,84718,89618,38216,18911,874
Nonoperating income (expense)4,878(663)4,508(2,116)(1,315)(3,655)(2,860)
Investment income, nonoperating 68,086    
Other nonoperating income (expense)4,878(669)(3,578)(2,116)(1,315)(3,655)(2,860)
Interest and debt expense(1,291)(1,449)(138)(3)(999)(312)(1,199)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes     (3,871)1,150
Income from continuing operations before equity method investments, income taxes:26,7409,49422,21716,77716,0688,3518,965
Loss from equity method investments      (45)
Other undisclosed income (loss) from continuing operations before income taxes(2,429)(1,997)(4,535)(4,892)(3,763) 45
Income from continuing operations before income taxes:24,3117,49717,68211,88512,3058,3518,965
Income tax expense (benefit)(1,852)(477)(1,384)(706)9,049(1,123)(1,990)
Other undisclosed income (loss) from continuing operations 1  (1)1 
Income from continuing operations:22,4597,02116,29811,17921,3537,2296,975
Income (loss) from discontinued operations(434)2,63141021711
Income before gain (loss) on sale of properties:22,0259,65216,30211,18921,3557,2466,986
Other undisclosed net loss   (1)   
Net income:22,0259,65216,30211,18821,3557,2466,986
Net loss attributable to noncontrolling interest(45)(36)(29)(36)(47)(31)(26)
Other undisclosed net income (loss) attributable to parent(1)  1   
Net income attributable to parent:21,9799,61616,27311,15321,3087,2156,960
Preferred stock dividends and other adjustments  (1)(1)(1)(1)(1)
Net income available to common stockholders, basic:21,9799,61616,27211,15221,3077,2146,959
Other undisclosed net income available to common stockholders, diluted  111 1
Net income available to common stockholders, diluted:21,9799,61616,27311,15321,3087,2146,960

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:22,0259,65216,30211,18821,3557,2466,986
Other comprehensive income (loss)(589)14(376)(1,975)1,730(1,518)(2,232)
Other undisclosed comprehensive income (loss)(1)  1   
Comprehensive income:21,4359,66615,9269,21423,0855,7284,754
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(43)(27)(18)(16)(62)(28)1
Other undisclosed comprehensive income, net of tax, attributable to parent1    1 
Comprehensive income, net of tax, attributable to parent:21,3939,63915,9089,19823,0235,7014,755

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: